Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Michael Jacob Wagner, M.D.

Concepts (164)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hemangiosarcoma620242153.670 Why?
Sarcoma12202418011.960 Why?
Chondrosarcoma420222961.800 Why?
Sarcoma, Synovial320241531.050 Why?
Bone Neoplasms6202225291.000 Why?
Osteosarcoma420228970.980 Why?
Soft Tissue Neoplasms6202311590.930 Why?
Hemangioendothelioma120231110.830 Why?
Hemangioendothelioma, Epithelioid12023540.820 Why?
Anthracyclines220212840.790 Why?
Gastrointestinal Stromal Tumors320246170.780 Why?
Ifosfamide320242320.780 Why?
Neoplasms, Connective and Soft Tissue12020340.700 Why?
Liposarcoma220222890.700 Why?
Antineoplastic Combined Chemotherapy Protocols82024117420.690 Why?
Doxorubicin5202322240.640 Why?
Phosphatidylcholines220174050.620 Why?
Vascular Endothelial Growth Factor Receptor-2120215460.610 Why?
Leiomyosarcoma120224220.610 Why?
Receptor, EphA212017410.560 Why?
Antigens, Neoplasm2202119930.540 Why?
Neoplasms, Second Primary1202410520.520 Why?
Rare Diseases120216220.520 Why?
Vincristine1201710360.480 Why?
Protein-Tyrosine Kinases1202424250.480 Why?
MAP Kinase Signaling System1202114860.450 Why?
Liposomes120177830.430 Why?
Liposarcoma, Myxoid22024600.410 Why?
Up-Regulation1202141250.400 Why?
RNA Interference1201728320.310 Why?
Gene Expression Regulation, Neoplastic2202185540.300 Why?
RNA, Small Interfering1201734300.290 Why?
Breast Neoplasms22024210190.270 Why?
SEER Program2202214500.260 Why?
Nanoparticles1201719580.250 Why?
Phenylurea Compounds220175290.220 Why?
Retrospective Studies112024806470.210 Why?
Antineoplastic Agents52017136420.190 Why?
Vesicular Transport Proteins120243760.190 Why?
Young Adult112024592600.180 Why?
Humans3620247615960.180 Why?
Ubiquitin Thiolesterase120244550.180 Why?
Mesna12020620.180 Why?
Interleukin-15120211850.180 Why?
Protective Agents120201500.160 Why?
Adult1720242212100.160 Why?
Pyrimidinones120213850.150 Why?
Adjuvants, Immunologic1202410360.150 Why?
Aged1420241693100.150 Why?
Antineoplastic Agents, Alkylating120226170.150 Why?
Mastectomy, Segmental120239550.150 Why?
High-Throughput Nucleotide Sequencing2202436390.150 Why?
Neoplasm Recurrence, Local2202092800.150 Why?
In Situ Hybridization, Fluorescence1202425100.150 Why?
Cell Proliferation42021104510.150 Why?
Ribosomal Protein S6 Kinases, 70-kDa120171030.140 Why?
Xenograft Model Antitumor Assays3202136050.140 Why?
Middle Aged1420242209210.140 Why?
Mice, Nude2202136140.140 Why?
Molecular Targeted Therapy3202028110.140 Why?
Genetic Heterogeneity120207320.140 Why?
Solitary Fibrous Tumors12017670.140 Why?
Male1720243608460.130 Why?
Female1820243927050.130 Why?
Thrombocytopenia1202411820.130 Why?
Kaplan-Meier Estimate3202264840.130 Why?
Receptors, Antigen, T-Cell2202325470.130 Why?
Pyridones120218090.130 Why?
Leukocytes, Mononuclear1202218440.120 Why?
Incidence22024213550.120 Why?
Retinal Vein Occlusion120161490.120 Why?
Pyridines2201728750.120 Why?
Quinazolines1202113710.120 Why?
Anemia1202415090.120 Why?
Membrane Proteins2202178590.110 Why?
Cancer Vaccines1202110510.110 Why?
Treatment Outcome92021646850.110 Why?
Tumor Cells, Cultured1202161310.110 Why?
Aged, 80 and over72024589840.110 Why?
Neoplasm Metastasis2202149150.110 Why?
Tissue Distribution1201722640.100 Why?
Survival Analysis32021100900.100 Why?
Prognosis32022296290.100 Why?
Adolescent72024883260.100 Why?
Child52024801580.100 Why?
Drug Evaluation, Preclinical1201713340.100 Why?
Proto-Oncogene Proteins1202445140.100 Why?
Developing Countries1202428850.090 Why?
Immunotherapy, Adoptive1202114690.090 Why?
Macaca mulatta1201723290.090 Why?
Lymphocyte Activation1202154850.090 Why?
Ovarian Neoplasms2201748780.090 Why?
Angiogenesis Inhibitors2201720480.080 Why?
Apoptosis3202194900.080 Why?
Neoplasm Invasiveness1201735970.080 Why?
Neoplasm Proteins1202136170.080 Why?
CD4-Positive T-Lymphocytes1202143690.080 Why?
Gastrointestinal Neoplasms120169540.080 Why?
Proto-Oncogene Proteins c-akt1201724570.080 Why?
Uterine Neoplasms1201714200.080 Why?
Phosphoproteins1201724480.080 Why?
Chemotherapy, Adjuvant1201635140.070 Why?
T-Lymphocytes22023101940.070 Why?
Disease-Free Survival1201768150.070 Why?
Adaptor Proteins, Signal Transducing1201728980.070 Why?
Macrophages1202157670.070 Why?
Neovascularization, Pathologic1201626450.070 Why?
Databases, Factual1202079680.060 Why?
Aspirin1201631330.060 Why?
HLA-A Antigens120242230.060 Why?
Mice32021815390.050 Why?
Antibodies, Monoclonal1202091770.050 Why?
Cross-Sectional Studies12024261290.050 Why?
Cohort Studies12024414950.050 Why?
Survival Rate12015127230.050 Why?
Myeloablative Agonists120212090.040 Why?
Prospective Studies22023544230.040 Why?
Toll-Like Receptor 4120235790.040 Why?
Animals420211684750.040 Why?
Gene Expression Profiling1201594200.040 Why?
Tumor Microenvironment2202238780.040 Why?
Cell Line, Tumor32021169900.040 Why?
Cytotoxicity, Immunologic1202113510.040 Why?
Coculture Techniques1202113410.040 Why?
Thromboxanes12016450.030 Why?
Inhibitory Concentration 50120174650.030 Why?
Risk Factors22021742130.030 Why?
Antibiotics, Antineoplastic120206780.030 Why?
Immunity120229960.030 Why?
Cyclophosphamide1202122200.030 Why?
United States12023723400.030 Why?
Clinical Trials, Phase I as Topic120163260.030 Why?
Retreatment120165980.030 Why?
Immunologic Memory1202113590.030 Why?
Transplantation Conditioning1202115900.030 Why?
Giant Cell Tumor of Bone120151180.030 Why?
Disease Susceptibility1202017870.030 Why?
Antineoplastic Agents, Phytogenic120176210.030 Why?
Necrosis1201716110.030 Why?
Immunoenzyme Techniques1201517040.030 Why?
Proto-Oncogene Proteins c-kit120167270.030 Why?
Fatal Outcome1201618350.020 Why?
Tumor Burden1201718920.020 Why?
Neoadjuvant Therapy1202228280.020 Why?
Protein Kinase Inhibitors2201756720.020 Why?
Paclitaxel1201717320.020 Why?
Combined Modality Therapy1202085270.020 Why?
Pilot Projects1202186330.020 Why?
Infant22021361930.020 Why?
Child, Preschool22021422320.020 Why?
Neoplasm Staging12020111200.020 Why?
Dose-Response Relationship, Drug12016107660.010 Why?
Cell Differentiation12021115300.010 Why?
Proteomics1201538480.010 Why?
Infant, Newborn12021262020.010 Why?
Disease Progression12016135100.010 Why?
Time Factors12021399690.010 Why?
Genetic Predisposition to Disease12020179040.010 Why?
Positron-Emission Tomography1201564840.010 Why?
Transcription Factors12017121300.010 Why?
Disease Models, Animal12016182550.010 Why?
Risk Assessment12017239960.010 Why?
Mutation12020300530.010 Why?
Tomography, X-Ray Computed12015205680.010 Why?
Wagner's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (164)
Explore
_
Co-Authors (6)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.